Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Clinical trial NCT06447701 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06447701
Sponsor: Zhujiang Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Diseases Ischemic Stroke Ischemia Stroke Cerebral Infarction Atherosclerosis of Artery Atheroscleroses, Intracranial

Start date: 2025-10-30
Primary completion: 2025-12-31
Enrollment: 486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.